X

ALONET 50 TABLET 50mg (REVISED FORMULA)

Product Information

Registration Status: Inactive

SIN10549P

THIS PRODUCT HAS BEEN DEREGISTERED!

ALONET 50 TABLET 50mg (REVISED FORMULA) is approved to be sold in Singapore with effective from 1998-12-12. It is marketed by DRUG HOUSES OF AUSTRALIA PTE LTD, with the registration number of SIN10549P.

This product contains Atenolol 50mg in the form of TABLET. It is approved for ORAL use.

This product is manufactured by PHARMACHEMIE BV in HUNGARY, andTeva Pharmaceutical Works Company Ltd. in NETHERLANDS.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Product Reference
Loading...


Description

A cardioselective beta-adrenergic blocker possessing properties and potency similar to propranolol, but without a negative inotropic effect.

Indication

For the management of hypertention and long-term management of patients with angina pectoris

Mechanism of Action

Like metoprolol, atenolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting sympathetic stimulation. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension. Higher doses of atenolol also competitively block beta(2)-adrenergic responses in the bronchial and vascular smooth muscles.

Pharmacokinetics

Absorption
Approximately 50% of an oral dose is absorbed from the gastrointestinal tract, the remainder being excreted unchanged in the feces.
Distribution
Metabolism
Hepatic (minimal)
Elimination

Toxicity

LD50=2000-3000 mg/kg(orally in mice). Symptoms of an atenolol overdose include a slow heart beat, shortness of breath, fainting, dizziness, weakness, confusion, nausea, and vomiting.

Active Ingredient/Synonyms

1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol | 2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide | 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide | Atenololum | Atenolol |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank

Pharmfair.com uses cookies to improve your browsing experience. We'll assume you're ok with this, but you can opt-out if you wish. Peace!